Psychologists in Gladwin, MI Accepting Medicare
3 Psychologists found. Showing 1 - 3
 Dr. Erika Dianis, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 655 E. Cedar Ave., Gladwin, MI 48624 Phone: 989-426-9295 |
 Mr. Ross Oldenburg, M.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 655 E Cedar Ave, Gladwin, MI 48624 Phone: 989-426-9295 Fax: 989-426-2251 |
Destiney Rose Mcwilliams Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 500 Quarter St Apt 3, Gladwin, MI 48624 Phone: 989-313-3395 |
News Archive
New microRNA mechanism for regulating brain function
Non-coding regions of the genome - those that don't code for proteins - are now known to include important elements that regulate gene activity. Among those elements are microRNAs, tiny, recently discovered RNA molecules that suppress gene expression.
Ultrasound-based technology for measuring brain pressure could replace surgery
A new invention may be on the verge of replacing a costly cranial surgical procedure currently being performed on some traffic accident victims and other patient groups. The ultrasound-based technology has now been granted CE approval for the European market.
Reform debate circles back to costs, and how to pay for them
In the White House's pitches for health care reform, controlling costs has replaced universal coverage as the leading imperative to overhaul the system. A top White House economist, Christina Romer, said in a public appearance Monday, "Good health care reform is good economic policy," the San Francisco Chronicle reports. "Fixing what's wrong with our health care system is no longer a luxury we hope to achieve – it's a necessity we cannot postpone any longer" (Abate, 6/9).
Scientific breakthrough could mean greater protection for asthmatics
Colds are known to be a major trigger of asthma attacks and asthmatics are far more likely to suffer a severe attack during a cold and even end up being hospitalised.
Positive data from POZEN's PA32540 Phase 3 studies presented at AHA 2013 stroke conference
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from the combined results of two Phase 3 studies of PA32540, an antiplatelet therapy of enteric-coated (EC) and immediate-release omeprazole, in patients with previous cerebrovascular disease.
› Verified 1 days ago
Clinical Social Workers
Counselors
Occupational Therapists
Pharmacists
Dentists
Psychologists